Because matrix matters! The path to liver disease is paved with MMPs and collagen
Posted: November 11, 2022
It’s Not Just Support. It’s Solutions. DiaPharma and QuickZyme Know Matrix Matters! Matrix Metalloproteases (MMPs) degrade collagen and elastin. As indicators of inflammation and disease, they are key targets for drug development. Biliary Atresia – MMP-7 has garnished much research support for its role in mediating biliary injury in the disease. NAFLD/NASH – Serum MM...Read More
What's New at DiaPharma?
Posted: November 9, 2022
It’s Not Just Support. It’s Solutions. DiaPharma in the Community DiaPharma staff supports many impactful causes. DiaPharma and our staff proudly sponsor events close to our hearts and our community. Most recently, DiaPharma sponsored Ross’s Race in the Alzheimer’s Association Walk to End Alzheimer’s®, and the Circle Tail Golf Classic for Circle Tail assistance...Read More
DiaPharma has a lot to share at The Liver Meeting® - come see us!
Posted: October 27, 2022
It’s Not Just Support. It’s Solutions. VISIT DIAPHARMA AND VLVbio AT THE LIVER MEETING®! A LOT has happened since the last in-person AASLD The Liver Meeting® and DiaPharma has a lot to share about new studies using CK18/K18-M30® and CK18/K18-M65® as blood-based biomarkers in the world of NASH, acute alcohol-associated hepatitis, and DILI. Booth # 712 is where Team DiaPharma ...Read More
Thank you for connecting with DiaPharma at Midwest Platelet!
Posted: October 20, 2022
It’s Not Just Support. It’s Solutions. THANK YOU TO THOSE WHO CONNECTED WITH US AT THE MIDWEST PLATELET CONFERENCE DiaPharma is proud to celebrate 25 years in the hemostasis and coagulation business. Thank you to those who stopped by our booth at the Midwest Platelet Conference. We welcomed the opportunity to talk all things bleeding & clotting, and demo new technology for...Read More
Overworked staff? The T-TAS® 01 platelet function analyzer can lighten the burden
Posted: October 18, 2022
It’s Not Just Support. It’s Solutions. T-TAS® 01 PL Assay: One test, one result, one total answer for platelet function Help address staffing and budgetary challenges with a frontline test for overall total platelet function Single assay with easy-to-interpret test result provides simple and comprehensive platelet reactivity status Consolidate testing from multiple platforms, for ...Read More
Special Pricing on Non-Invasive, Non-Destructive Ecotoxicology Assays
Posted: October 11, 2022
It’s Not Just Support. It’s Solutions. Environmental Impact Matters. PERFORM ENDOCRINE DISRUPTOR STUDIES WITHOUT KILLING THE FISH NON-INVASIVE, EASY TO USE, ACCURATE ECOTOXICOLOGY ELISAs Contact your territory manager for special 4th quarter pricing on Vitellogenin ELISAs! Use TECO® Mucus Collection Swabs and test kits to test fish: follow individuals and populations over time e...Read More
Go further than FEV1 and FVC – Mechanistic Biomarkers for Lung Disease
Posted: October 11, 2022
It’s Not Just Support. It’s Solutions. A Case for Letting Endotype Lead the Way in Drug Development… Neutrophilic VS Eosinophilic The molecular mechanisms that drive chronic lung disease are heterogenetic. To evolve past a “one drug fits all approach”, toward a more individualized and precision approach, pharmaceutical companies are focusing on drugs th...Read More
Factor XIII Assays to Fit Your Needs
Posted: September 30, 2022
t’s Not Just Support. It’s Solutions. Factor XIII Activity Assays – The Right Fit for your Needs Manual and automated solutions for measuring FXIII Activity Technofluor® Factor XIII Fully automated on the Ceveron s100 for the determination of FXIII activity levels. Minimal hands-on time Data in under 30 minutes Single calibration per lot No need for blank samples Sensitive at...Read More
Endotyping for Clinical Trial Success with COPD, bronchiectasis, asthma
Posted: September 29, 2022
It’s Not Just Support. It’s Solutions. Endpoints for clinical trials in lung disease could be better… FEV1 and FVC are relatively blunt tools for getting a complete picture of a disease state – they do not provide information on the pulmonary microenvironment. Inflammation is a hallmark of chronic lung diseases and an important piece of the bigger picture to understand when...Read More
Measure fibrosis in a more meaningful way using TOTAL collagen assays
Posted: September 28, 2022
It’s Not Just Support. It’s Solutions. Let DiaPharma introduce you to a new partner in fibrosis research, QuickZyme Biosciences DiaPharma is excited to announce that we now offer QuickZyme products. QuickZyme knows, “Matrix Matters”. Collagens are a main component of the extracellular matrix and are the most abundant proteins in the body. Collagens play important roles in cell gr...Read More
Clot Club #34
Posted: September 26, 2022
VACCINE-INDUCED THROMBOTIC THROMBOCYTOPENIA (VITT): INSIGHTS FROM ISTH 2022 ...Read More
AASLD The Liver Meeting™ 2022
Event Date: November 4 - 8, 2022
Event Location: Booth 712, Washington, DC
DiaPharma offers non-invasive biomarker tests for researching NASH, AH, DILI, and metabolic syndrome. Visit us and our VLVbio colleagues at booth 712 to discuss M30® and M65® Cytokeratin/Keratin 18 ELISAs for assessing hepatocyte apoptosis/necrosis, and explore our full portfolio of liver injury biomarkers. Research use only in U.S. and Canada. ...Read More
Tools for Sickle Cell Disease Research
Posted: September 22, 2022
It’s Not Just Support. It’s Solutions. Tools for Sickle Cell Disease Research September is National Sickle Cell Awareness Month. From Anti-Hemoglobin S antibodies, coagulation kits, and biomarker assays, to exciting new instrumentation for clotting analysis, DiaPharma has what matters covered for impactful Sickle Cell research. Research projects like gene therapy require many deci...Read More
18th Midwest Platelet Conference
Event Date: October 6 - 8, 2022
Event Location: University of Michigan, Ann Arbor, MI
...Read More
Time to include Human TSP2 in your next NASH study?
Posted: September 14, 2022
It’s Not Just Support. It’s Solutions. Time to include Thrombospondin-2 in your next NASH study… Thrombospondin-2 has been identified by transcriptomics as an emerging NASH biomarker. Protein analysis shows that it has promise for use in studying NAFLD, NASH, metabolic disease, and diabetes. This Human TSP2 ELISA kit, from ImmunoDiagnostics, is proven reliable for clin...Read More
Clot Club #33
Posted: August 31, 2022
EMERGING THERAPEUTIC TARGETS FOR HEREDITARY ANGIOEDEMA ...Read More
Thank you for celebrating with DiaPharma!
Posted: August 25, 2022
It’s Not Just Support. It’s Solutions. THANK YOU TO THOSE WHO CELEBRATED WITH US AT THSNA 2022 DiaPharma is proud to celebrate 25 years in the hemostasis and coagulation business. Thank you to those who stopped by our booth at the Thrombosis and Hemostasis Summit of North America (THSNA) this year in Chicago, IL. We welcomed the opportunity to talk all things bleeding & clotting,...Read More
What's New at DiaPharma?
Posted: August 15, 2022
It’s Not Just Support. It’s Solutions. Meet Genesis Cautivar West Territory Manager Genesis Cautivar joined DiaPharma in July 2022. He is a native of Vancouver, British Columbia, Canada and currently resides in the Dallas-Fort Worth, Texas Metroplex. He received his B.S. in Medical Technology from Walla Walla University (WA). He has many years of experience in clinical labs, technica...Read More
Celebrate with us at THSNA and Learn about T-TAS® 01
Posted: August 15, 2022
It’s Not Just Support. It’s Solutions. STOP BY BOOTH 416 TO CELEBRATE WITH US AT THSNA 2022 DiaPharma is proud to celebrate 25 years in the hemostasis and coagulation business at the Thrombosis and Hemostasis Summit of North America (THSNA) this year in Chicago, IL. We would love to see old friends and meet new acquaintances August 16th – 18th at the Sheraton Grand Chicago in Booth...Read More